Literature DB >> 33515656

Transparency, trust and minimizing burden to increase recruitment and retention in trials: a systematic review.

Patrizia Natale1, Valeria Saglimbene2, Marinella Ruospo2, Andrea Matus Gonzalez3, Giovanni Fm Strippoli2, Nicole Scholes-Robertson3, Chandana Guha3, Jonathan C Craig4, Armando Teixeira-Pinto3, Tom Snelling5, Allison Tong3.   

Abstract

OBJECTIVE: To describe patient perspectives on recruitment and retention in clinical trials. STUDY DESIGN AND
SETTING: Systematic review of qualitative studies that reported the perspective of adult patients with any health condition who accepted or declined to participate in clinical trials.
RESULTS: Sixty-three articles involving 1681 adult patients were included. Six themes were identified. Four themes reflected barriers: ambiguity of context and benefit - patients were unaware of the research question and felt pressured in making decisions; lacking awareness of opportunities - some believed health professionals obscured trials opportunities, or felt confused because of language barriers; wary of added burden - patients were without capacity because of sickness or competing priorities; and skepticism, fear and mistrust - patients feared loss of privacy, were suspicious of doctor's motivation, afraid of being a guinea pig, and disengaged from not knowing outcomes. Two themes captured facilitators: building confidence - patients hoped for better treatment, were supported from family members and trusted medical staff; and social gains and belonging to the community - altruism, a sense of belonging and peer encouragement motivated participation in trials.
CONCLUSION: Improving the visibility and transparency of trials, supporting informed decision making, minimizing burden, and ensuring confidence and trust may improve patient participation in trials.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Barriers; Clinical trials; Patient recruitment; Patient retention; Research; Strategies

Year:  2021        PMID: 33515656     DOI: 10.1016/j.jclinepi.2021.01.014

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  5 in total

Review 1.  Patient-centred clinical trial design.

Authors:  Allison Tong; Nicole Scholes-Robertson; Carmel Hawley; Andrea K Viecelli; Simon A Carter; Adeera Levin; Brenda R Hemmelgarn; Tess Harris; Jonathan C Craig
Journal:  Nat Rev Nephrol       Date:  2022-06-06       Impact factor: 42.439

2.  earlyMYCO: A Pilot Mother-Child Cohort Study to Assess Early-Life Exposure to Mycotoxins-Challenges and Lessons Learned.

Authors:  Carla Martins; Ricardo Assunção; Ana Costa; Débora Serrano; Lia Visintin; Marthe De Boevre; Carl Lachat; Arnau Vidal; Sarah De Saeger; Sónia Namorado; Cristina Vidigal; Elisabete Almeida; Paula Alvito; Carla Nunes
Journal:  Int J Environ Res Public Health       Date:  2022-06-23       Impact factor: 4.614

3.  Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools.

Authors:  Julia E McGuinness; Gauri Bhatkhande; Jacquelyn Amenta; Thomas Silverman; Jennie Mata; Ashlee Guzman; Ting He; Jill Dimond; Tarsha Jones; Rita Kukafka; Katherine D Crew
Journal:  Cancer Prev Res (Phila)       Date:  2022-06-02

4.  Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews.

Authors:  Edgardo Rodríguez-Torres; Margarita M González-Pérez; Clemente Díaz-Pérez
Journal:  Contemp Clin Trials Commun       Date:  2021-08-03

Review 5.  Including ethnic minorities in dementia research: Recommendations from a scoping review.

Authors:  Bianca Brijnath; Samantha Croy; Julieta Sabates; Antonia Thodis; Stephanie Ellis; Fleur de Crespigny; Annette Moxey; Robert Day; Annette Dobson; Cerise Elliott; Cathy Etherington; Mary Ann Geronimo; Danijela Hlis; Amit Lampit; Lee-Fay Low; Nicola Straiton; Jeromey Temple
Journal:  Alzheimers Dement (N Y)       Date:  2022-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.